OTTAWA, Feb. 2 (Xinhua) -- Canadian Prime Minister Justin Trudeau announced Tuesday that Canada's National Research Council-owned Royalmount facility will produce millions of COVID-19 vaccine shots developed by Maryland-based Novavax.
The Canadian company in Montreal submitted its vaccine to Health Canada for regulatory approval last Friday. Its production is expected to start in the fall this year as the global market is contending with delivery delays and protectionist measures.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
